🔎 Trials Near Me

홈 › 만성 폐쇄성 폐질환 › 테네시

테네시의 만성 폐쇄성 폐질환 임상 시험

만성 폐쇄성 폐질환 관련 연구 16개가 테네시 내 여러 지역에서 참여자를 모집하고 있습니다.

테네시의 도시

공식 연구 텍스트(영어)

Ensifentrine (MK-5884) Study for the Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in Adults With a History of Moderate or Severe Exacerbations While Receiving Standard of Care (SOC) (MK-5884-031/RPL554/ENHANCE-3)

  • M3 Wake Research, Inc. ( Site 4440), Chattanooga
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT07874815

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

  • Research Site, Chattanooga
  • Research Site, Franklin
피험자 모집 중2상
40세 이상 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT07082738

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

  • Chattanooga Research and Medicine- Site Number : 8400026, Chattanooga
  • Premier Research Center, Llc- Site Number : 8400146, Hendersonville
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT07190222

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

  • Clinical Trials Center of Middle Tennessee, LLC, Franklin
  • Premier Research Center, LLC, Hendersonville
피험자 모집 중2/3상
35세 ~ 80세 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT07363694

Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators

  • The University of Tennessee Graduate School of Medicine, Knoxville
피험자 모집 중4상
40세 이상 · 모든 성별 · 2026. 10. 19. 업데이트됨 · NCT07133880

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

  • Meharry Medical College- Site Number : 8400133, Nashville
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 10. 19. 업데이트됨 · NCT07190209

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

  • Research Site, Hendersonville
  • Research Site, Knoxville
  • Research Site, Lebanon
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT06878261

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

  • GSK Investigational Site, Knoxville
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT06961214

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation

  • GSK Investigational Site, Franklin
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT06959095

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

  • Research Site, Chattanooga
  • Research Site, Franklin
  • Research Site, Tullahoma
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06283966

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

  • Fort Sanders Regional Medical Center (StatCare), Knoxville
피험자 모집 중
40세 ~ 80세 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT06035120

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

  • Vanderbilt University Medical Center, Nashville
피험자 모집 중2상
40세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT07059091

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

  • Research Site, Franklin
  • Research Site, Johnson City
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06883305

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

  • GSK Investigational Site, Knoxville
피험자 모집 중3상
40세 ~ 75세 · 모든 성별 · 2026. 7. 28. 업데이트됨 · NCT07177339

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

  • Methodist LeBonheur Healthcare, Memphis
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 7. 10. 업데이트됨 · NCT05181826

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

  • The Jackson Clinic, PA, Jackson
피험자 모집 중관찰 연구
50세 이상 · 모든 성별 · 2025. 8. 5. 업데이트됨 · NCT06122077

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.